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ABSTRACT  
Cardiovascular diseases are the leading cause of deaths throughout the world. Vascular 
diseases are mostly treated with autografts and blood vessel transplantations. However, 
traditional grafting methods have several problems including lack of suitable harvest sites, 
additional surgical costs for harvesting procedure, pain, infection, lack of donors and even no 
substitutes at all. Recently, tissue engineering and regenerative medicine approaches are used 
to regenerate damaged or diseased tissues. Most of the tissue engineering investigations have 
been based on the cell seeding into scaffolds by providing a suitable environment for cell 
attachment, proliferation and differentiation. Because of the challenges such as difficulties in 
seeding cells spatially, rejection and inflammation of biomaterials used, the recent tissue 
engineering studies focus on scaffold-free techniques. In this paper, the development of novel 
computer aided algorithms and methods are developed for 3D bioprinting of scaffold-free 
biomimetic macrovascular structures. Computer model mimicking a real human aorta is 
generated using imaging techniques and the proposed computational algorithms. An 
optimized three-dimensional bioprinting path planning are developed with the proposed self-
supported model. Mouse embryonic fibroblast (MEF) cell aggregates and support structures 
(hydrogels) are 3D bioprinted layer-by-layer according to the proposed self-supported 
method to form an aortic tissue construct. 
 
KEYWORDS: 3D bioprinting; scaffold-free tissue engineering; tissue engineering of 
macrovascular structures; biomimetic modeling 
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Introduction 
Cardiovascular diseases are the primary reasons of deaths and they rank among the top ten 
leading causes of morbidity and mortality (Nemeno-Guanzon et al., 2012). Autografts and 
blood vessel transplantation are found to be the most effective treatments for vascular 
diseases. However, autografts have limitations such as lack of autografts in donor site or the 
patient’s deficient health condition. Recently, tissue engineering and regenerative medicine 
research have been developed for regeneration of damaged or diseased vascular tissues.  
In earlier tissue engineering strategies, the cells are seeded into synthetic, biological or 
composite scaffolds. Especially, synthetic-biologic hybrid scaffold with their biochemical 
and mechanical properties mimicking the native ECM are strong 3D cell culture platforms for 
cell physiology and tissue printing studies (Tibbitt and Anseth 2009). However, fabrication of 
a controlled porous structure with the desired internal architecture might be challenging with 
traditional scaffold fabrication techniques. Despite these difficulties, several researchers have 
developed methods for design and bioprinting of functionally gradient porous scaffolds with 
controllable variational pore size and heterogeneous porous architecture (Khoda et al., 2011; 
Khoda et al., 2013).  
Recently, there are a few studies focusing on vascular and valve tissue engineering using 3D 
printing techniques. In order to mimic complex 3D anatomy and heterogeneity of aortic 
valve, root wall and tri-leaflets are 3D printed with poly-ethylene-glycol-diacrylate (PEG-
DA) hydrogels. Porcine aortic valve interstitial cells (PAVIC) seeded scaffolds maintained 
near 100% viability over 21 days (Hockaday et al., 2012). Another study demonstrates that 
encapsulated aortic root sinus smooth muscle cells (SMC) and aortic valve leaflet interstitial 
cells (VIC) are viable within the bioprinted alginate/gelatin aortic valve hydrogel conduits 
(Duan et al., 2012). In (Daniela et al., 2013), human mesenchymal stem cells were 
encapsulated into agarose hydrogels and cell-laden hydrogel was 3D printed submerged in a 
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hydrophobic high-density fluorocarbon, which mechanically supports the construct and 
afterwards can be easily removed. Additionally, cell-laden microengineered hydrogel 
constructs with an embedded network of vascular –like microchannels were sequentially 
assembled in a biphasic reactor in order to achieve 3D tubular constructs (Du et al., 2011). 
Although there are few studies relevant to the vascular tissue engineering, these approaches 
are based on scaffold or cell-laden hydrogel based which limit the construction of an entirely 
biomimetic and biological blood vessels (Norotte et al., 2009). In addition, chronic 
inflammation, thrombosis and rejection after in-vivo implantation could be unpredictable side 
effects due to the degradation of the materials and the cell-material interaction (Nemeno-
Guanzon et al., 2012). Recently, there have been a few research focusing on scaffold-free 
tissue engineering of small-diameter, multi-layered, tubular vascular and nerve grafts (Marga 
et al., 2012). A platform-assisted 3D inkjet bioprinting system was utilized in order to 
fabricate NIH 3T3 mouse fibroblast-based tubes with an overhang structure having a post-
printing cell viability above 82% (Xu et al., 2012). Microvascular units consisting of 
cylindrical or spherical multicellular aggregates are fabricated by the parenchymal and 
endothelial cells. Afterwards, microvascular units are located in the macrovascular network 
for the perfusion supporting self-assembly and the connection to the existing network (Jakab 
et al., 2010). However, the formation of large amounts of spherical or cylindrical aggregates 
requires a lot of manual work and the fusion process of the spheroids is completed in 5-7 
days.  
In this paper, 3D bioprinting of a macro-vascular tissue such as aorta directly from medical 
images is proposed. A computer model of a macro-vascular tissue is generated by 
biomimicking a real human aorta model directly from medical images. To support the 
bioprinted mechanically-weak live cell aggregates, a novel self-supporting methodology is 
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developed. The computer aided algorithms are developed to bioprint self-supporting cell 
aggregates in 3D for fully biological and scaffold-free macro-vascular tissue engineering. 
 
Materials and Methods 
3D Bioprinting System and Hydrogel Preparation 
The cells and support biomaterials are 3D printed using Novogen MMX Bioprinter. The 3D 
bioprinter can print hydrogel biomaterials as well as cylindrical cell aggregates with its two 
deposition heads equipped with 500 μm diameter sized glass capillaries as shown in Error! 
Reference source not found.. While it is possible to control the printer with its own software 
for simple geometries, novel path planning strategies for both cell and support material must 
be developed for complex geometries. The 3D bioprinter can then be controlled directly by 
the generated scripts and it can print cell aggregates and support hydrogels layer by layer to 
form the designed tissue structure.  
A bio-inert, thermo-responsive hydrogel called NovoGel was used as a support material for 
3D printing of the developed models. The preparation of 2% (w/v) NovoGel (Organovo) was 
carried out with phosphate buffered saline (PBS: Thermo Scientific Hyclone 1X) with Ca
2+
 
and Mg
2+
 salts. The solution was mixed with magnetic stirrer and it was kept in microwave 
for 1 minute on high power settings. Then, the solution was located in a water bath set at 
70°C. NovoGel solution was autoclaved following standard liquid sterilization procedures 
(Kucukgul et al., 2013).  
Cell Culture and Staining 
Early passage primary mouse embryonic fibroblast (MEFs isolated from C57BL/6 strain) 
cells were immortalized using SV40 Large T genome using standard protocols. Cells were 
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cultured at 37 
o
C and under 5% CO2 using DMEM culture medium (Sigma, Germany) 
supplemented with 10% FBS (Biochrom KG, Germany), 1% Penicillin-Streptomycin 
(Biological Industries, Israel), 1% L-glutamin (Biological Industries, Israel), 55 µM β-
mercaptoethanol (Sigma, Germany) and 0.8 µg/ml puromycin (Sigma, Germany). 
Subconfluent and low passage cultures were used for this study.  
Bio-ink Preparation  
Immortalized MEF cells were cultured in 15 cm-diameter culture dishes. Cells were detached 
from the culture plate using two different approaches. Cells were either detached using 0.1% 
t ypsin (Biological Industries, Israel) for 10 minutes (Exp1), or 2.5 mM EGTA (ethylene 
glycol-bis(2-aminoethyl ether)-N,N,N´,N) (Idranal VI, Fluka, Germany) in PBS. Following 
detachment, trypsin or EGTA was neutralized using serum containing medium. Following 
detachment, cells were centrifuged at 200 x g and supernatant was discarded. The cell pellet 
was resuspended to obtain 10 x 10
6
 cells / 20 ml medium incubated at 37°C in 15 ml-conical 
tubes under rotation (PTR-30 Grant-Bio rotator, U.K). Following pelleting, cells were 
resuspended in 1 ml medium and transferred into 1.5 ml Eppendorf tubes and centrifuged 
again (1000 x g). Then, the cell pellets were drawn into capillary tubes. Following incubation, 
cells inside the capillary tubes were extruded into cylindrical grooves on agarose gel (2% in 
PBS). Then, plates were covered with culture medium and put into the incubator until 
cylindrical bioinks are formed. Cylindrical bioink MEF cells were drawn back into capillary 
tubes and bioprinting was performed using the 3D bio-printer. 
For continuous bioprinting, cells were centrifuged at 200 x g. The pellet was resuspended to 
have 20 x 10
6
 cells / 6.5 ml and transferred into 15 ml-conical tubes. Following rotation at 
37°C, cells were pelleted and transferred into Eppendorf tubes. Cell pellets in 1.5 ml 
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Eppendorf tubes (60 x 10
6
 cells in total) were transferred into capillaries by continuous 
bioprinting. 
Staining and Western Blotting 
To detect cylindrical cell aggregate fusion, Hoechst 33342 (Invitrogen, U.S.A) and Acridine 
orange (AO) (Invitrogen, U.S.A) staining was used. Immortalized MEF cells stained 15 min. 
with either Hoechst 33342 (final concentration 1 μg/ml) or AO (final concentration 2 μg/ml) 
and used for bioink preparation using protocols explained below. Florescent signals were 
analyzed under an Olympus IX-70 fluorescent microscope (Olympus, Japan). 
Cellular stress and viability was analyzed by immunoblotting. Anti-rabbit anti-caspase 3 (Cell 
Signaling Technology, U.S.A), anti-rabbit anti-LC3B (Sigma-Aldrich, Germany), anti-mouse 
anti-beta actin (Sigma-Aldrich, Germany), anti-mouse anti-SQSTM1/p62 (Abnova, Taiwan), 
anti-rabbit anti-procaspase 3 (Pro-Csp-3) (Santa Cruz Biotechnology, U.S.A), anti-rabbit 
anti-PARP (Cell Signaling Technology, U.S.A) and anti-rabbit anti-cleaved PARP (Cell 
Signaling Technology, U.S.A) antibodies were used as primary antibodies. Peroxidase 
conjugated anti-rabbit (Jackson Laboratory, U.S.A) and peroxidase conjugated anti-mouse 
(Jackson Laboratory, U.S.A) antibodies were used as secondary antibodies. Cylindirical 
bioinks  were transferred into 1.5 ml Eppendorf tubes, centrifuged at 1000 x g for 10 minutes 
and pellets were lysed in RIPA buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1 % NP40, 0.25 
% Na-deoxycholate) supplemented with complete protease inhibitor cocktail (Roche, 
Germany) and 1 mM phenylmethylsulfonyl fluoride (PMSF). Protein concentration was 
measured by using BCA protein assay. Protein extracts were separated in 12–15 % SDS-
polyacrylamide gels (SDS-PAGE) and then transferred to nitrocellulose membranes 
(Advantec MFS Inc, Japan) using electroblotting. Membranes were blocked in 5 % non-fat 
milk in PBS-T (3.2 mM Na2HPO4, 0.5 mM KH2PO4, 1.3 mM KCl, 135 mM NaCl, 0.05 % 
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Tween 20, pH 7.4) for 1 h. Following incubation with primary antibodies and secondary 
antibodies, blots were developed on X-ray films (Fuji, Japan) using West-pico 
chemiluminescence detection reagent (Pierce, Germany).  
3D Bioprinting of Aortic Vascular Structure Using Self-Support 
A roadmap of the proposed approach is presented in Error! Reference source not found.. 
Firstly, a medical image obtained from computer tomography (CT) or magnetic resonance 
imaging (MRI) is used to obtain the geometric and topological information of the targeted 
vascular tissue (Figure 2.a). Secondly, the STL (mesh) model of aorta converted to a 
parametric smooth surface (Figure 2.b). The computer model is then sliced for the layer-
based 3D bioprinting process and the proposed methodology has been implemented in every 
slice to compute the locations for both cellular aggregates and support structures. To support 
the bioprinted live cell aggregates, a novel self-supporting methodology is developed (Figure 
2.c). The generated cell and support 3D printing paths are used to control the bioprinter for 
3D printing of a biomimetic aortic construct (Figure 2.d). The details of the proposed 
methodology are given below. 
3D Imaging 
To be able to mimic and 3D bioprint a blood vessel, the original geometry of the vessel has to 
be obtained and transformed in a way that the vessel can be used in computer aided 
modeling. In this work, the main abdominal aorta model is used to highlight the proposed 
methods capabilities for 3D bioprinting of macrovascular structures. For segmentation of the 
aorta from the rest of the internal organs, region growing tools of Mimics software (Mimics, 
Medical Image Segmentation for Engineering on Anatomy) are used as shown in Figure 2.a. 
The initial geometric information of the model is then represented as a mesh model or 
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stereolithography (STL) model as shown in Figure 3.b, which will be used for computer-
aided biomodeling methodology described at the following sections. 
Biomodeling of Aorta 
As shown in Figure 3.a-b, the derived STL model of the aorta is not smooth and represented 
by numerous triangular facets. A novel biomodeling method is developed to convert these 
mesh (triangular facets) structures into smooth parametric surfaces to be used for 3D 
bioprinting.  
A marching algorithm is developed to calculate section curves starting from bottom edge 
curve bEC  until the top edge curve tEC . The developed algorithm marches the 
vertices , 1..{ }i l l LV v   of all the faces 1..{ }i i IF f   of the STL model to form the section curves. 
The set of sections is represented as 1..{ }m m MS s  , and each section is defined with n vertices 
(points) represented as , , 1..{ }m n m n n NS s  . Furthermore, for each section curve there will be 
center points 1..{ }m m MCP cp   reflecting the area weight-based center points for that section 
curve, and respective radius values 
1..{ }m m MR r   reflecting the radius of the maximally-
inscribed sphere of that section curve.  
The computation of the Cartesian coordinate center point and the respective radius value of 
the m
th
 section curve with n vertices is as follows:  
th
, , 1..{ } A set of  points in the sectionm n m n n NS s n m       
mcp = 
, , ,
1.. 1.. 1..
( ) ( ) ( )
, ,
m n m n m n
n N n N n N
s x s y s z
N N N
  
   
 
 
 
     (1) 
  ,
1..
min ,m m n m
n N
s cpr


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When the top section is reached by marching through the section curves, the algorithm builds 
a B-spline curve, which will be the centerline for the parametric surface. Mathematically, this 
parametric B-spline centerline curve is defined as (Piegl and Tiller 1997): 
 ,
1
( ) ( ) 0 1
m
i p i
i
CC u N u cp u

     Where B-spline basis function is; 
 
1
,0
1 if 
( )
0 otherwise
i i
i
u u u
N u 
 




        (2) 
1
, , 1 1, 1
1 1
( ) ( ) ( )
i p ii
i p i p i p
i p i i p i
u uu u
N u N u N u
u u u u
 
  
   

 
 
 
Where cpi’s are the control points, and the Ni,p(u) are the pth-degree B-spline basis functions 
as defined above with the knot vector U= {u0,…,um}. 
Then the parametric B-spline surface of the aorta model is generated using the centerline 
curve with respect to the average radius value of relevant center points as shown in Figure 
3.c. A general form of the swept surface is given by (Piegl and Tiller 1997): 
 ( , )kS u v = ( )CC u + M(u)T(v)  Where 0 ≤ u ≤ 1 and 0 ≤ v ≤ 1  
  ( ) cos( ), sin( )avg avgT v r v r v         (3) 
Where M(u) is a 3x3 matrix incorporating rotation and nonuniform scaling of T(v) as a 
function of u. 
As explained above, generating a smooth aortic model from the mesh model is determined 
using Algorithm 1. 
Algorithm 1. Generating NURBS Surface(s) from Mesh 
Input: 
Mk:   Mesh 
,{ }b tEC EC :  two edge curves on Mesh 
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1..{ }i i IF f  :  a set of faces on Mesh 
, 1..{ }i l l LV v  :  a set of vertices on Mesh 
Output: 
( , )kS u v : generated B-spline Surface(s) 
Start 
Initializei ← 1, m ← 1 
S1← bEC  
Mark vertices of S1 as visited in set V 
cpm← calculate cpm using Equation(1) 
rm← calculate rmusing Equation(2) 
m ← m + 1 
For (m=2 to M){// for all section curves 
  For (i=1 to I) {// for all faces 
    If ( , , 1 , 2 1i l i l i lv v v    // only one vertex of a face fiis visited) Then { 
      // determine subsequentsection’s (Sm) points (vertices)  
If , 0i lv  Then , ,m n i ls v         
If , 1 0i lv   Then , 1 , 1m n i ls v         
If , 2 0i lv   Then , 2 , 2m n i ls v   
} 
} 
  Mark vertices of the Smcurve as visited in set V 
cpm← calculate cpm using Equation(1) 
  rm ← calculate rmusing Equation(2) 
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} 
( )CC u ← approximate a centerline curve with the control points using Equation (2)  
( , )kS u v ← Build the surface along ( )CC u with respect to its control point’s average radius 
value using    Equation (3) 
End 
 
Self-Supporting Model Support Structure Generation for Aorta 
Previous works on scaffold-free 3D bioprinting of vascular structures are based generally on 
simple vertical extrusions (Christopher et al., 2013; Marga et al., 2012). Not only because of 
its complex geometry, but also due to the dynamic structures of both cells and hydrogels, it is 
challenging to build such structures in 3D. Here, an anatomically correct 3D bioprinting of 
vessels is aimed; therefore, mechanically-weak cellular aggregates should be supported in 3D 
until cell fusion.  
After the smooth surface model of aorta ( , )kS u v is generated, an optimum 3D bioprinting 
topology needs to be determined in order to obtain an anatomically correct representation of 
the vessel. The path planning for both cellular aggregates and hydrogel support structures is 
calculated in this section. Both cellular aggregates and support structures are printed by a 
glass capillary in a gel like form layer by layer to form the 3D tissue construct. Because of 
the fact that bioprinted materials are not self shape conserving, both cells and support 
structures should accordingly be placed on the valleys of the preceding layer (shown in 
Figure 4) in order to provide cell fusion and structure conservation and most importantly, to 
reach correct anatomical model of the original vessel. 
 
Since the targeted vascular construct is printed layer by layer, the vessel’s surface 
representation is sliced with successive planes which resulted in contour curves 
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 ,0 ,0 1..{ }j j j totalLayersC t c   for each layer, the total number of contour slices equals to 
totalLayers, as shown in Figure 5.a and calculated by Equation (4).  
 
capillary
ModelHeight
totalLayers
d
         (4) 
Where ModelHeight is the total height of the aorta model and the dcapillary is the diameter of 
the capillary. 
The number of cylinders for each layer is then determined by the maxStepj value using 
Equation (5) 
maxStepj= topSupport + totalLayers – j      (5) 
where topSupport is the total number of support cylinders that is specified just for the top-
most layer (in this work, topSupport variable equals to 4). To conserve the general shape of 
the vessel on each layer and to prevent the deformation of weak cellular aggregates, each 
contour curve is offset using the maxStepj value of the specific layer on xy-plane as shown in 
Figure 5.a. The initial offset amount , , 1..{ } jj i j i i maxStepO o  for a layer can be found by the 
following formula: 
     , /2 1j i j capillaryo maxStep i d           (6) 
 Where dcapillary is diameter of the glass capillary used. 
The initial offset amount for a layer is strictly positive, resulting in exterior offset curves. 
However, offset amount is dropped by the capillary diameter for each successive cylinder on 
that layer. Therefore, after (maxStepj/2) cylinders, offset amount will become negative 
resulting in interior offset curves as shown in Figure 5.a. Thus, cellular aggregates are 
supported from both inner and outer directions. As 
,0 ( )jc t defines a contour curve of the 
surface on a given height and a curve parameter t, then the offset curves with respect to the 
oj,i will be: 
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      , ,0 , , 1..max jj i j j i j i i Stept c t o N tc    Where,    (7) 
 ,j iN t  = unit normal vector on curve  ,0j tc at a parametric location t.  
The support structures are printed first, and then the cellular aggregates in order to prevent 
cell outflow and to preserve anatomically correct shape of the modeled vessel as shown in 
Figure 5.b.  
As can be seen from Equation (4-7), the total number of cylinders at a layer ( cellular 
aggregates + support structures) are increasing by one at each layer through the bottom and 
calculated based on the geometry of the aorta model. An increase in the number of support 
cylinders for the top-most layer results in a thicker outer support for the planned model. 
The diameters of the support structures at a given layer j can be approximated by Equation 
(8), as layer numbers increase through top, the support diameters tend to converge to the 
aorta model: 
jSupport Diameter ( ) contour's diameterj capillarytotalLayers topSupport j d           (8) 
Where contour’s diameter is the approximation of the diameter of the model’s contour at 
layer j. Since the developed algorithm uses the model directly from medical images, the 
generated contours aren’t necessarily circular in shape. 
After appropriate sections of the cell composition and support structure are determined for 
each layer, the tool path planning for cell-biomaterial topology is calculated. Then, layer by 
layer, these cylindrical aggregates of the cell and gels will be printed accordingly a file that is 
generated by Algorithm 2 using a 3D bioprinter. 
Algorithm 2. Self-Supporting Model Support Structure Generation 
Input: 
( , )kS u v :  generated NURBS Surface 
dcapillary:  diameter of the glass capillaries 
A
cc
ep
te
d 
Pr
ep
rin
t
15 
 
Output: 
Finalized vascular model, with support structure 
Path planning for 3D-Bioprinting (a compatible script file for the 3D-Bioprinter) 
Start 
Initialize totalLayers←(surfaceHeight/dcapillary)+1, j← 1, n← 1, i← 1, contourLevel ← 0 
Initialize maxStepj← topSupport+totalLayers-j 
For ( j = 1 to totalLayers) { 
  contourLevel←contourLevel + dcapillary 
  If (cj,0← contouring the surface from a given contourLevel, results in a closed curve) Then 
{ 
    Initialize oj,i← (maxStepi/2)×dcapillary 
    For ( i = 1 to maxStepi) { 
      cj,i← offset cj,0 by oj,iusing Equation (7) 
      Initialize curveLength← length(cj,i) 
If (curveLength < minSegmentLength) Then {Exit For} // to prevent self intersection in 
offset operations 
      If ( i = maxStepi/2 or i = maxStepi/2+1) Then { 
      Store cj,i and curveLength in the script file as cellular structure} 
      Else{Store cj,i and curveLength in the script file as support structure} 
      oj,i←calculate oj,iusing Equation (6) 
    } 
maxStepj← topSupport + totalLayers – j  } 
} 
End 
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Results & Discussion 
Implementation of the Self-Supporting Model 
Rhinoscript language is used for implementation of the presented algorithms. However, the 
algorithms can also be implemented by variety of different programming languages. 
Therefore, the developed algorithms are fully portable. The initial geometry is obtained by 
using Mimics software and its sample human aorta MRI data. Because of the 3D printer 
capillary size, the original MR data is scaled down by almost 50%. The whole aorta surface 
model, which is extracted from the STL file by Algorithm 1, is 50 mm high and its diameter 
is around 9 mm. For the illustration of the proposed method, a partial aorta model with 3.5 
mm height is extracted with Algorithm 1 and its path planning for 3D bioprinting is obtained 
by Algorithm 2. As illustrated in Figure 2.c, by the cross sectional view, blue cylinders are 
representing support structures, where red ones represent fibroblast cells. 
MEF cell aggregates and support structures are 3D printed layer-by-layer according to the 
developed Self-Supporting method. As shown in Figure 6, the MEF cells are successfully 
printed at the valleys formed by the support material (hydrogel).  
The bioprinter’s deposition speed for support structures and cellular aggregates is set 3 mm/s 
and 2 mm/s respectively. The optimum speeds are determined after various bioprinting trials. 
The bioprinter can only aspirate 65 mm hydrogel/cell aggregates into its capillaries, therefore 
the total printing time is effected by this limitation. Printing a 65 mm piece of material 
approximately takes about 1 minute, for both cellular aggregates and support structures, 
including aspiration and chilling times. The bioprinting path for the aorta model shown in 
Figure 2 consists of 85 support material pieces (12 layers, as shown with blue cylinders in 
Figure 2.c) and 16 cellular aggregate pieces ( for 8 layers,  as shown with red cylinders in 
Figure 2.c). The total printing time for the model was approximately 100 minutes.  
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In order to compare the final printed structure against the designed structure, a picture of the 
4
th
 layer was taken during the printing process as shown in Figure 7. Several different 
arbitrary points were marked on the taken picture (red points in Figure 7) in order determine 
the distance between the middle point (blue circle in Figure 7) and cell/gel stripe boundaries 
using ImageJ software. Three random points (1-2-3) are taken from the outer support material 
boundary, three points (4-5-6) are taken from the outer cellular aggregate boundary, and the 
next three points (7-8-9) are taken from the intersection border of the fifth and sixth support 
material cylinder, and the last three points (10-11-12) are taken from the inner cellular 
aggregate boundary of the 4th layer. The picture of the printed structure and the designed 
model are overlapped so that the same distances are measured on the model according to the 
marked points and shown in Table 1.   
The accuracy of the printed cellular aggregates changes between 91% - 95%, while it is 
around 97% for support structures. The reason of reaching a higher accuracy in support 
structures relies on that the fact that the hydrogel material is mechanically stronger than the 
cellular aggregates. Additionally, overall cumulative errors of the support structure may 
affect the accuracy of the cellular aggregates adversely.  
 
Bioink analysis and optimization 
Programmed cell death and cellular stress responses are important issues to face with when 
dealing with cells grown outside their natural environments (Gozuacik and Kimchi 2004; 
Gozuacik and Kimchi 2007). A major stress mechanism activated during conditions faced by 
cells during tissue engineering studies is macroautophagy (Autophagy herein).  
Initially, the bioink was prepared using cylindrical cell aggregates method (see the Materials 
and Methods section). We tested whether incubation of the bioink (20, 40 or 80 min.) within 
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the capillaries would result in cellular stress and death sensitization. As shown in Figure 8.a, 
the stripe printing protocol led to the activation of autophagic stress responses as shown by 
LC3-I to LC3-II conversion and p62 degradation. Moreover, apoptotic cell death was 
activated under this conditions and the amplitude was proportional to incubation time: 
Caspase-3 activation and PARP cleavage were observed starting from 20 min. of incubation 
and reaching a maximum at 80 min (Figure 8.a). Cell cylinders printed under these conditions 
were followed for 4 days. Although immediately after printing bioink cylinders looked 
compact and healthy, following 1 day incubation, the cell cylinders started to dissolve, most 
probably, as a result of the death of some of the cells that make up the cell cylinders (Figure 
8.b).  
Encouragingly, printed cylindrical cell aggregates stained using two different color dyes were 
able to fuse under our experimental conditions (Figure 9.a). To improve the printing protocol 
and minimize the stress imposed on the cells of the bioink, we omitted the capillary 
incubation and manipulation steps. We switched to the continuous bioprinting protocol 
design details of which was explained above. This new approach also allowed us to obtain 
longer cell cylinders and made printing possible in multiple layers and in complicated forms. 
Using the continuous bioprinting, we were able to design and 3D print MEF bioink cylinders 
corresponding to the size and shape of a complete human aorta ring (Figure 9.b). To check 
whether apoptotic death mechanisms were activated in cells making-up the ring, proteins 
were extracted and immunoblots were performed. Although caspase-3 activation could be 
seen in control extracts of the same cell type treated with a death inducer, there was no 
activation in continuously printed bioink ring cells (Figure 9.c). Therefore, there was no 
apoptotic cell death activation in continuously printed bioink cells, allowing cell fusion and 
robust ring formation. 
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Conclusion 
In this study, novel computer aided algorithms are developed in order to 3D bioprint hybrid 
cell and biomaterial scaffold-free macro-vascular structures. The tool path design and 3D 
printing parameters are optimized for a well-formed 3D printing. After the segmentation of a 
part of aorta with imaging and segmentation software, the attained geometry of the aorta was 
converted to CAD model. In order to develop path planning and optimization, parametric 
surfaces are generated from mesh. For 3D bioprinting of cylindrical cell aggregates according 
to the aorta model, a self-supporting structure is developed with computational algorithms. 
Support structure and MEF cells are successfully printed with the Self-Supporting 
methodology. A CAD software package, Rhino3D using Rhinoscript language, was used for 
the implementation of all methodologies. The outputs of the developed algorithms are 
instruction for the Novogen MMX 3D Bioprinter. The modeled part of the aortic tissue 
structure was successfully 3D bioprinted.  
The proposed bioprinting strategies increase the contact of cylindrical cellular aggregates in 
adjacent bioprinted layers and facilitate the fusion of cells. However, the amount of support 
structures and therefore the printing time increase depending on the size of the modeled 
structure. Since the 3D bioprinter is equipped with 75 and 85 mm long capillaries for cell 
aggregates and support material respectively, the maximum length of material that can be 
extruded each time is limited. Therefore, the capillary is loaded with support structure or cell 
aggregates each time during the printing process which slows down the process and prevents 
a full-continuous printing. Even the proposed bioprinting strategies enable the use of the 
maximum capillary volume for each extrusion and therefore provide a semi-continuous 
bioprinting process, it is still challenging to create large structures. 
Although the 3D bioprinter is placed in a biosafety cabinet to ensure the sterile conditions, a 
large cell construct may not survive a long printing process and the cell viability may 
A
cc
ep
te
d 
Pr
ep
rin
t
20 
 
decrease with time. In order to keep the printed cells alive, a small amount of culture medium 
is dispensed on the top of the printed cellular aggregate to prevent the dehydration. As 
mentioned above, the tissue construct is bioprinted on a flat mold prepared with 2% agarose 
solution. The mold could dry and deform based on the humidity of the environment and 
therefore should also be hydrated during the printing process. 
The bioprinting system has been used to print various types of cells including human/mouse 
smooth muscle, endothelial and fibroblast cells. However, obtaining sufficient amount of 
cells using general cell culture protocols can take a long time based on the cell type. 
Therefore, the cell types affect the bioink preparation time before the printing process.   
To optimize the bioink preparation, autophagy analyses were performed during bioink 
preparation and after the printing of aortic structure. The results showed that the cell 
aggregates were printed without any apoptotic cell death activation allowing cell fusion and 
robust tissue formation. 
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List of Figure Legends 
Figure 1. 3D Bioprinter. 
Figure 2. Roadmap of the proposed methodology. (a) Segmentation of an aorta from 
abdominal region based on region growing. (b) The STL (mesh) model of aorta converted to 
a parametric smooth surface. (c) Representation of the ‘Self-Supporting’ method, with vessel 
(grey), cellular aggregates (red) and support structures (blue). (please see the color version) 
(d) 3D printed MEF cellular aggregates. 
Figure 3. (a-b) STL file of the aorta, mesh structure. (b) The modeled Aorta’s edge curves 
(green & red) and the initial section curve (red). (b-c) STL (mesh) surface of aorta, the initial 
center points & smoothed representation of the centerline curve. Generation of smooth 
NURBS surface from mesh model (aorta). 
Figure 4. Three consecutive example layers showing how support structures (blue) and 
cellular aggregates (red) are placed on the valleys of the preceding layer. 
Figure 5. (a) The slicing process of aorta and the placement of the support structures & 
cellular aggregates at jth layer. (see the color version) (b) The bioprinting topology for three 
example consecutive layers, of both support structures and cellular aggregates. 
Figure 6. 3D printed MEF cell aggregates of originally mimicked aorta in 'Self-Supporting' 
model. 
Figure 7.  Comparison of the accuracy between designed and printed structures  
Figure 8. Cellular stress and death activation following capillary incubation and stripe 
printing of the bioink. (a) MEFs were prepared following the stripe printing protocol and 
incubated 20, 40, 80 min. in glass capillaries prior to printing (capillary) or not (Control). 
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LC3 lipidation (LC3-I to LC3-II conversion) and p62 degradation were used as autophagic 
activity markers. Pro-caspase-3 and PARP cleavage were used as markers of apoptosis. β-
actin was used as a loading control. (b) Phase contrast microscopy and Hoechst nuclear 
staining pictures of stripes immediately after printing (Day 0) or following incubation for 1 or 
4 days. 
Figure 9. Printed stripes could fuse and form biologically relevant aorta ring-like tissue 
precursors. (a) Fusion of stripes stained with Acridine Orange (Red) or Hoechst (Blue) dyes. 
(b) Image of multiple layers of MEF bioink that was 3D printed in the shape of a human aorta 
ring. (c) Analysis of apoptotic cell death in protein extracts obtained from printed aorta rings. 
Exp1, Experiment 1 and Exp2, Experiment 2 (See Materials and Methods for experiment 
details). Active caspase-3 immunoblots were performed on the stripes. Cont, positive control 
mouse embryonic fibroblast cells treated O/N with tunicamycin (1 µg/ml). β-actin, loading 
control. 
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Table 1. Measurements of the designed and bioprinted structures 
Point 
Numbers 
Designed 
Structure 
(mm) 
Printed 
Structure 
(mm) 
Error (%) 
1 10.602 10.261 3.22 
2 10.637 10.323 2.95 
3 10.764 10.473 2.70 
4 5.138 5.595 8.89 
5 5.164 5.409 4.74 
6 5.046 5.301 5.05 
7 7.432 7.231 2.70 
8 7.724 7.562 2.10 
9 7.632 7.45 2.38 
10 4.217 3.939 6.59 
11 4.139 3.853 6.91 
12 4.031 3.819 5.26 
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Figure 9 
